Stock 600380 JOINCARE PHARMACEUTICAL GROUP INDUSTRY CO.,LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Other languages Joincare Pharmaceutical Group Industry Co.,Ltd.

Equities

600380

CNE000001816

End-of-day quote Shanghai S.E.
Other stock markets
 23:00:00 14/05/2024 BST 		5-day change 1st Jan Change
12.98 CNY -1.37% Intraday chart for Joincare Pharmaceutical Group Industry Co.,Ltd. +2.04% +4.42%
04-25 Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
04-18 Joincare Pharma Says Flu Drug Phase 3 Trial Attains Primary Endpoint MT

Other languages

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024
Joincare Pharmaceutical Successfully Completes TG-1000 Phase III Study
Joincare Pharmaceutical Group's 2023 Profit Falls 4%; Shares Slide 4%
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023
Livzon Pharma to Trial JP-1366 Tablets as Reflux Esophagitis Drug
Livzon Pharmaceutical Appoints Former Joincare Exec as Vice President
Boan Biotechnology, Joincare Sign Exclusive License Deal for Respiratory Disease Treatment
Shandong Boan Biotechnology Co., Ltd. Enters into Agreement with Joincare Pharmaceutical Group Industry Co., Ltd
Joincare Pharmaceutical, Guangzhou Fermion Technology Get Nod to Trial Analgesic Drug
Livzon Pharmaceutical to Continue Getting Services from Joincare Pharmaceutical
Joincare Pharma’s 210 Drugs Included in China's Medical Insurance Catalog
Joincare Gets Nod to Trial Pain Relief Drug
Joincare Pharma Shortlisted For China’s Drug Procurement Program
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023
Joincare Pharma Unit Gets Go Signal from China for Phase 3 Trial of Endometriosis Drug
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023
Livzon Pharmaceutical Gets Nod to Register Blonanserin Tablets
Joincare Pharma's Unit Gets Nod for COVID-19 Vaccine Trial
Joincare Pharma Unit Gets Nod for Anti-Bacterial Drug
Joincare Pharmaceutical Group Industry Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 600380 Stock
  4. News Joincare Pharmaceutical Group Industry Co.,Ltd.
  5. Other languages